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The reaction of trans-1,4-dichloro-2-butene 1 with selected phenols affords (E)-1,4-bis(aryloxy)-
2-butenes 2a-d which are converted into bis-thiosemicarbazones 3a-h via the reactions with 
thiosemicarbazide and 4-methyl thiosemicarbazide, respectively. Similarly, 4-methyl-5-
ethoxycarbonyl-2,3-dihydro-1,3-thiazoles 4a-h are synthesized via the reaction of bis-
thiosemicarbazones 3a-h with ethyl 2-chloroacetoacetate. trans-1,4-Dithiocyanato-2-butene 5 is 
obtained from the reaction of KSCN and trans-1,4-dichloro-2-butene 1. Furthermore, the bis-2-
amino-1,3,4-thiadiazoles 6k and l are obtained from the reaction of trans-1,4-dithiocyanato-2-
butene 5 with thiosemicarbazide and 4-methyl thiosemicarbazide, respectively. These 
compounds are characterized by elemental analyses, infrared, 1H-, 13C-NMR and mass 
spectrometry. Finally, the microbial features of all compounds are determined. Some of them 
exhibited microbial activities at low level, and the electronic absorption spectra of the 
compounds 3b,d,f and h are measured in organic solvents (MeOH, DMF, DMSO and 1,4-
dioxane) with various polarities. 
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Thiosemicarbazones are a class of small molecules that have been evaluated over the last 50 
years as antivirals and as anticancer therapeutics, as well as for their parasiticidal action against 
Plasmodium falciparum and Trypanasoma cruzi which are the causative agents of malarya and 
Chagas’ disease, respectively.1-4  In a previous study, the bis(thiosemicarbazone) complexes of 
copper have shown special promise as radiopharmaceuticals, as illustrated by the per fusion 
imaging agent.5-9 Thiosemicarbazones have been reported to exhibit antituberculosis activity.10,11 
In addition, 1,3-thiazoles, 1,3,4-thiadiazoles and their derivatives exhibit various biological 
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activities such as antituberculosis,11 antimicrobial,12 anti-inflammatory,13 antiviral, 
anticonvulsant,14 antihypertensive,15 local anesthetic,16 anticancer,17 hypoglycemic,18 and 
cytotoxic activities, among others.19 1,3,4-Thiadiazoles and related compounds are of great 
interest in chemistry owing to their bioactivity of certain plant growth regulating effects as well 
as antimicrobial activity.20 Antitubercular activites of thiadiazoles linked with aromatic cycles 
through the oxy-methylene group have also been reported and compounds of this type have 
shown inhibition on both cycloxygenase and 5-lipoxygenase activities.13,21 Lee and coworkers 
have synthesized some thiadiazoles with antihelmintic activities.22 More recently, sulfonamide 
derivatives of 1,3,4-thiadiazoles have been reported to behave as a modulator of anticancer 
therapies in combination with some cytotoxic compounds.23,24 
In view of these facts, the aim of the present study was to obtain thiosemicarbazone, 1,3-thiazole 
and 2-amino-1,3,4-thiadiazole composites (Scheme 1) as possible antitiberculosis, antimicrobial, 
anti-inflammatory, antiviral, anticonvulsant, antihypertensive, local anesthetic, anticancer, 







Scheme 1. Synthetic pathway for the preparation of target compounds 2-6 
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Results and Discussion 
 
In the first part of this study, bis aldehyde and ketone derivatives 2a-d were obtained from the 
reaction of trans-1,4-dichloro-2-butene 1 with phenolic aldehydes and ketones in absolute 
ethanol and KOH in reasonable good yields (Scheme 1). 
In the IR spectra of compounds 2a-d, one strong and sharp absorption band was observed at 
1681-1668 cm-1 belonging to the carbonyl function. The (CHO) Fermi doublet stretching 
frequency and (C-O-C) stretching frequency were observed at 2875-2756 and 1268-1179 cm-1, 
respectively. In the 1H-NMR spectra of compounds 2a-d proton signals belonging to the 
methylene groups were recorded at 4.98-4.73 ppm (-O-CH2) integrating for four protons. 
Aldehyde protons (CHO) were observed at 10.83-9.86 ppm integrating for two protons. In the 
1H-NMR spectra of compound 2d, no signal derived from the ketone function was observed.  -
HC=CH- proton signals were seen as singlet for compounds 2a-d at 6.26-6.10 ppm integrating 
for two protons. In the 13C-NMR the signal of the methylene function of compounds 2a-d, the 
OCH2 group, was observed at 68.71-67.62 ppm. Compounds 2a-d the signals belonging to C=O 
and -HC=CH- functional groups appeared at 193.64-188.03 and 128.50-127.78 ppm, 
respectively. 
Bis thiosemicarbazone derivatives 3a-h were synthesized via the reaction of the bis aldehyde 
and ketone derivatives with thiosemicarbazide and 4-methyl thiosemicarbazide, respectively 
(Scheme 1). In the IR spectral data of compounds 3a-h, the ν(C=O) signals 1681-1668 cm-1 
belonging to the starting aldehydes and ketone starting materials, were absent, while the 
symmetric and asymmetric stretch bands belonging to the NH2 group were observed at 3269-
3150 cm-1. NH and CH=N stretching frequency were observed at 3155-3140 and 1602-1585 cm-1 
in the IR spectra, respectively. In the 1H-NMR spectra of compounds 3a-h, the proton signals 
appearing for 3a-d compounds were recorded at 8.37-7.89 ppm (-NH2) integrating for four 
protons (D2O exchanged) and the proton signals appearing for 3e-h compounds were recorded 
8.66-8.14 ppm (NHMe) integrating for two protons (D2O exchanged). N(2)H protons were 
observed at 11.67-10.11 ppm integrating for two protons (exchangeable with D2O) (Scheme 1). 
In the 1H-NMR spectra of compounds 3a-h, another characteristic proton signal belonging to 
CH=N was observed at 8.87-7.97 ppm integrating for two protons. CH=N proton signal for 
compounds 3d and 3h which were ketone thiosemicarbazones were not observed in the 1H-NMR 
spectra. -HC=CH- proton signals were seen as singlet for compounds 3a-h at 6.27-6.05 ppm 
integrating for two protons. The 13C-NMR spectral data of compounds 3a-h, showed no C=O 
signal (193.64-188.03 ppm) but indicated the presence of the C=S functionality at 178.43-177.34 
ppm in line with reported spectral data.25-27 The 13C-NMR signals of CH=N function of 
azomethylene and -HC=CH- function of compounds 3a-h appeared at 147.63-136.13 and 
133.14-128.20 ppm, respectively. 
5-Ethoxy-2,3-dihydro-4-methylcarbonyl-1,3-thiazoles 4a-h were obtained from the Hantzsch 
reaction between bis-thiosemicarbazones 3a-h and ethyl 2-chloroacetoacetate (Scheme1). 
According to this reaction mechanism, the compounds of 4a-d or 4a'-d' could be two tautomeric 
forms while the compounds of 4e-h or 4e’-h’ are the resonance structures. However, the spectral 
data and physical parameters show that compounds of 4a-h have the exo-imine form in 2-
position of thiazole group (Scheme 2). 
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The most characteristic data for the synthesized compounds 4a-h was the ν(C=O) IR 
stretching frequency (1712-1682 cm-1), and the CH=N and C-O-C stretching frequencies were 
observed at 1611-1590 and 1103-1087 cm-1, respectively. In the 1H-NMR spectra of compounds 
4a-d the characteristic acidic NH proton signal of the thiazole rings (12.41-11.69 ppm) was the 
most important evidence for the structure of the 1,3-thiazol-2H-imine. In the 1H-NMR spectra, 
the N(2)H proton signal of the thiosemicarbazone was seen at 11.67-10.11 ppm. The spectral 
data showed that 1,2-dihydro-4-methyl-5-ethoxycarbonyl-1,3-thiazole compounds 4a-h were 
obtained and this result was in accordance with the literature.28 In the D2O exchange for the 
compounds, two NH proton signal disappeared in the 1H-NMR spectra. The C-4 methyl protons 
belonging to thiazoles 4a-h appeared at 2.57-2.47 ppm while the N(3)-methyl proton signals for 
thiazoles 4e-h were seen at 3.47-3.42 ppm. The ethyl ester CH3 protons appeared at 1.39-1.23 
ppm and the OCH2 protons were seen at 4.25-3.83 ppm integrating for four protons. -HC=CH- 
proton signal was seen as singlet for compounds 4a-h at 6.22-6.06 ppm integrating for two 
protons. The 13C-NMR signal of compounds 4a-h of CH3 and OCH2 ester group, the carbons of 
the thiazole ring CH3 and -OCH2- were seen at 68.36-12.52 ppm. This spectral data is the most 
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evidence for sp3 hybridized carbons. While C(5) and C(4) of the thiazole ring were observed at 
113.48-101.04 and 158.89-146.64 ppm respectively, the exo N(2')=C(2) carbon data of the 
thiazole ring appeared at 162.73-161.85 ppm in the 13C-NMR spectra. The most characteristic 
13C-NMR data was the carbonyl carbon (168.84-165.13 ppm) of the ethyl ester connected to the 
thiazoles and the absense of the thiosemicarbazones 3a-h C=S carbon signal (178.43-177.34 
ppm). 
(E)-1,4-Dithiocyanato-2-butene 5 was synthesized using the published methods.29 Bis 2-
amino-1,3,4-thiadiazole derivatives 6 were synthesized via the reaction of (E)-1,4-dithiocyanato-
2-butene 5 with thiosemicarbazide and 4-methyl thiosemicarbazides, respectively (Scheme 1). In 
the IR spectral data of compounds 6k and l, symmetric and asymmetric stretching bands 
belonging to the NH2 group of the thiadiazole were seen at 3269-3150 cm-1. The C=N stretching 
frequency was observed at 1640 cm-1 in the IR spectra. In the 1H-NMR spectra of compounds 6k 
and l, the proton signals of NH2 and NHMe group were recorded at 7.31 ppm and integrated for 
four protons (D2O exchanged) and 7.79-7.77 ppm integrating for two protons (D2O exchanged). 
S-Methylene proton signals were observed at 3.85 and 3.69 ppm integrating for four protons, 
respectively. A single peak belonging to the -HC=CH- proton signal was seen at 5.76 ppm 
integrating for two protons. In the 13C-NMR spectra of compounds 6k and l, the sp3 hybridize S-
CH2 and NH-CH3 carbons were seen 35.77, 35.38 and 31.11 ppm, respectively. sp2 Hybridized -
HC=CH- carbons were observed at 128.96, 129.37 ppm and sp2 hybridized carbon peaks, bound 
to the 2 and 5 position of the thiadiazole ring were seen at 149.24-147.89 and 170.95-169.70 
ppm, respectively. The data was consistent with the literature.20 
 
Antimicrobial activity 
Only a few of the compounds showed mild antimicrobial activity against Gram-positive and 
Gram-negative bacteria, but none showed antifungal activity against the fungus species (Table 
1). These particular bacterial species were tested because they are some of the most common 
pathogenic and undesirable bacteria frequently involved in food-poisoning incidents. The yeast-
like fungus C. albicans was included because it is a prevailing and widespread human pathogen. 
Compounds 3e, 4a and 4b were effective against the Gram-negative bacteria: E. coli, K. 
pneumoniae and P. aeruginosa, to some extent while compound 4d was slightly effective against 
the Gram-negative bacterium K. pneumoniae, but not effective against the other two. K. 
pneumoniae seems to be the most vulnerable bacteria against the compounds tested in this study. 
The compounds 3e and 6k are faintly effective against E. Faecalis and compound 4h was the 
only compound mildly effective against the Gram-positive bacterium S. aureus. The tested 
compounds did not show any activity whatsoever against the Gram-positive spore forming 
bacterium B. cereus and the yeast-like pathogenic fungus C. albicans. The reason of lower 
antimicrobial activity of compounds than we expected might be explained by the low solubility 
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Table 1. Antimicrobial activities for all compounds 






(mg/50 µl) Eco Kp Pa Ef Sa Bs Ca 
3a DMF 10,9 545 - - - - - - - 
3b “ 10,2 510 - - - - - - - 
3d “ 10,0 500 - - - - - - - 
3e DMSO 10,0 500 + + + + - - - 
3f DMF 10,4 520 - - - - - - - 
3g “ 10,0 500 - - - - - - - 
3h “ 10,4 520 - - - - - - - 
4a “ 10,2 510 + + + - - - - 
4b “ 10,0 500 + + + - - - - 
4d “ 7,4 370 - + - - - - - 
4e “ 13,0 650 - - - - - - - 
4f “ 9,8 490 - - - - - - - 
4g “ 6,1 310 - - - - - - - 
4h “ 10,2 510 - - - - + - - 
6k CHCl3 9,8 490 - - - + - - - 
Ceftazidime    +++ +++ +++ +++ +++ +++  
Triflucan          +++
Diameter (mm) of Inhibition Zone: < 5.0: (-); 5.5-10: (+); 11-16: (++); 17-24: (+++)  
Abbreviations: Ec: Escherichia coli ATCC 35218, Pa: Pseudomonas aeruginosa ATCC 10145, 
Kp: Klebsiella pneumoniae ATCC 13883, Ef: Enterococcus faecalis ATCC 29212, Sa: 
Staphylococcus aureus ATCC 25923, Bs: Bacillus cereus 709 Roma, Ca: Candida albicans 
ATCC 60193. 
 
Solvent and pH effects on the electronic spectra of compounds 3b,d,f and h 
The electronic absorption spectra of the compounds 3b,d,f and h were studied in organic 
solvents having various polarities, MeOH, DMF, DMSO and 1,4-dioxane. It can be seen from 
Tables 2 and 3 that the absorption spectra of all compounds, 3b,d,f and h, are considerably 
influenced by changing the solvent. The bands appearing at ca. 314-331 nm in dioxane and 302-
328 nm in MeOH for all compounds 3b,d,f and h are shifted to a higher wavelength in DMF and 
DMSO. The highest red shift is observed in DMSO. The compound has more red shift in DMF 
and DMSO than other solvents (Figure 1,3,5 and 7). This phenomenon can be explained by the 
high proton accepting character and the low ionization potential of these solvents.26,27 As can be 
seen from Table 2, the UV-vis transitions of related compounds except 1,4-Dioxane were 
observed as the Bathochromic shift, a change in solvent polarity resulted in solvatochromism. 
This can be explained by increasing the solvent polarities [ET(30)] values. 
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Table 2. Electronic spectral data (nm) of all substituted-thiosemicarbazones 3b,d,f and h 







3b 254, 283, 295, 314 258, 274, 328 250, 280, 296, 336 273, 300, 302, 353 
3d 242, 254, 280, 293, 327 261, 276, 320 
245, 260, 303, 317, 
335 
247, 264, 289, 305, 
337 
3f 2260, 281, 293, 324, 330 262, 293, 323 
268, 289, 291, 335, 
348 
265, 286, 292, 332, 
356 
3h 250, 269, 308, 331 279, 302 245, 265, 299, 332 259, 270, 306, 339 
 
The effect of the pH change on the electronic absorption spectra of all compounds were 
studied in MeOH solution by adding a small amount of 0.1 M HCl and KOH. The λmax of 3b,d,f 
and h in methanolic solution is not affected by adding a small amount of 0.1 M KOH. The bands 
at ca. 258-293 nm in neutral MeOH solution of all compounds 3b,d,f and h are shifted slightly to 
a higher wavelength in MeOH+KOH solution. On the other hand, the electronic absorption 
spectra of 3b,d,f and h show a considerable bathochromic effect when adding a small amount of 
0.1 M HCl in methanolic solution. After adding two drops of 0.1 M HCl to methanolic solution 
of these compounds, the bands appearing at ca. 258 and 293 nm in neutral solution show a slight 
blue shift and in addition, the band at ca. 302-328 nm in neutral solution of all compounds is 
shifted slightly to red visible region (Figure 2,4,6 and 8). Furthermore, a new broad band appears 
at ca. 294-335 nm, indicating that all compounds exist in the –NH.HCl form in acidic solution 
probably due to the capability of accepting a proton of the secondary amino group. 26,27 
 
Table 3. Electronic spectral data (nm) of all substituted-thiosemicarbazones (3b,d,f and h) in 
MeOH + HCl and in MeOH + KOH 
Compounds MeOH + HCl MeOH + KOH 
3b 255, 270, 294, 331 250, 278, 330 
3d 259, 272, 312, 329 260, 273, 328 
3f 260, 291, 310, 335 263, 304, 330 
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Figure 1. The electronic absorption spectra of Ligand 3b in: 1,4-Dioxane (bold-black line), DMF (thin-





Figure 2. The electronic absorption spectra of Ligand 3b in: MeOH (striped-black line), MeOH+KOH 




ISSN 1551-7012 Page 156 ©ARKAT USA, Inc. 
General Papers ARKIVOC 2009 (ii) 149-167 
 
 
Figure 3. The electronic absorption spectra of Ligand 3d in: 1,4-Dioxane (bold-black line), DMF 




Figure 4. The electronic absorption spectra of Ligand 3d in: MeOH (striped-black line), 
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Figure 5. The electronic absorption spectra of Ligand 3f in: 1,4-Dioxane (bold-black line), DMF 





Figure 6. The electronic absorption spectra of Ligand 3f in: MeOH (striped-black line), 
MeOH+KOH (bold-black line) and MeOH+HCl (thin-black line). 
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Figure 7. The electronic absorption spectra of Ligand 3h in: 1,4-Dioxane (bold-black line), DMF 






Figure 8. The electronic absorption spectra of Ligand 3h in: MeOH (striped-black line), 
MeOH+KOH (bold-black line) and MeOH+HCl (thin-black line).  
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Experimental Section 
 
General Procedures. Melting points were determined on a Gallenkamp melting point apparatus 
and are uncorrected. 1H- and 13C-NMR spectra were recorded on a Varian-Mercury 200 MHz 
spectrometer. The IR spectra were measured as potassium bromide pellets using a Perkin-Elmer 
1600 series FTIR spectrometer. Elemental analyses were carried out on a CHNO rapid elemental 
analyzer Hewlett-Packard 185 for C, H and N and results are with in 0.4% of the therotical 
values. UV/Vis spectra were recorded by means of a Unicam UV2-100 spectrophotometer. The 
MS spectra were measured with a Micromass Quattro LC/ULTIMA LC-MS/MS spectrometer in 
the positive ion mode using pyridine-methanol as solvent. All the chemicals were obtained from 
Fluka Chemie AG Buchs (Switzerland). Compound 2b has already been published in Acta 
Crystallographica.25 
 
General method for the synthesis bis aldehydes and bis ketone 2 
To a solution of hydroxy aldehyde and ketone derivatives (0.1 mol) in absolute ethanol (50 ml) 
were added KOH (0.1 mol) and trans-1,4-dichloro-2-butene 1 (0.025 mol). After the mixture 
was refluxed and stirred for 18 hours, the solution was filtered and the solid obtained. It was 
washed with deionized water, ethanol and diethyl ether. The precipitate formed was 
recrystallized from appropriate solvent to afford the desired compound. 
(E)-6,6'-[But-2-ene-1,4-diylbis(oxy)]bis(3-bromobenzaldehyde) (2a). The solid obtained was 
washed with H2O and recrystallized, (yield: 32%); mp 216 oC (from DMSO) (Found: C, 47.56; 
H, 3.12. C18H14Br2O4 requires C, 47.61; H, 3.11%); IR (KBr) (ν, cm-1), 3103 (Ar-CH), 2766-
2869 (CHO), 1678 (C=O); 1H-NMR (DMSO-d6) δ (ppm) 4.80 (s, 4H, O-CH2), 6.18 (s, 2H, -
HC=CH-), Ar-H [7.20-7.24 (d ,2H), 7.75 (s, 2H), 7.75-7.79 (d, 2H)], 10.30 (s, 2H, CHO); 13C-
NMR (DMSO-d6) δ (ppm) 68.08 (O-CH2), Ar-C: [112.52 (C), 116.64 (CH), 125.79 (C), 129.28 
(CH), 138.24 (CH), 159.28 (C)], 127.78 (-HC=CH-), 188.03 (C=O); MS(ESI-m/z): (M+Na+1)+: 
478; Anal. for C18H14Br2O4 (Mw 454.11). 
(E)-2,2'-[But-2-ene-1,4-diylbis(oxy)]di-1-naphthaldehyde (2c). The solid obtained was 
washed with H2O and recrystallized, (yield: 57%); mp 220 oC (from DMF-MeCN, 1:1) (Found: 
C, 78.69; H, 5.14. C26H20O4 requires C, 78.77; H, 5.09%); IR (KBr) (ν, cm-1), 3075 (Ar-CH), 
2793-2875 (CHO), 1668 (C=O); 1H-NMR (DMSO-d6) δ (ppm) 4.98 (s, 4H, O-CH2), 6.26 (s, 2H, 
-HC=CH-), Ar-H [7.44-7.51 (t, 2H), 7.56-7.69 (m, 4H), 7.91-7.95 (d, 2H), 8.21-8.26 (d, 2H), 
9.09-9.14 (d, 2H)], 10.83 (s, 2H, CHO); 13C-NMR (DMSO-d6) δ (ppm) 68.71 (O-CH2), Ar-C: 
[114.89 (C), 115.78 (CH), 123.77 (CH), 124.65 (CH), 128.08 (CH), 128.33 (C), 129.66 (CH), 
130.54 (C),137.69 (CH), 162.92 (C)], 128.50 (-HC=CH-), 191.20 (C=O); MS(ESI-m/z): 
(M+Na)+: 419.27; Anal. for C26H20O4 (Mw 396.43). 
(E)-1,1'-{4,4'-[But-2-ene-1,4-diylbis(oxy)]bis(4,1-phenylene)}diethanone (2d). The solid 
obtained was washed with H2O and recrystallized, (yield: 56%); mp 163 oC (from acetone-EtOH, 
1:1) (Found: C, 74.12; H, 6.19. C20H22O4 requires C, 74.06; H, 6.21%); IR (KBr) (ν, cm-1), 3065 
(Ar-CH), 1671 (C=O); 1H-NMR (DMSO-d6) δ (ppm) 2.52 (s, 6H, CH3), 4.73 (s, 4H, O-CH2), 
6.10 (s, 2H, -HC=CH-), Ar-H [7.04-7.08 (d, 4H), 7.90-7.94 (d, 4H)]; 13C-NMR (DMSO-d6) δ 
(ppm) 26.39 (CH3), 67.62 (O-CH2), Ar-C: [114.33 (CH), 130.57 (C), 130.63 (CH), 162.24 (C)], 
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128.03 (-HC=CH-), 193.64 (C=O); MS(ESI-m/z): (M+Na+2)+: 349.15; Anal. for C20H22O4 (Mw 
324.14). 
 
General method for the synthesis of bis thiosemicarbazone 3 
Compounds 2a-d (0.0025 mol) and thiosemicarbazite or 4-methyl thiosemicarbazite (0.010 mol) 
were heated to 160 °C without solvent in an oil bath with stirring for 4 h. DMF was added to the 
reaction content and dissolved. Then water was added to the solution and a solid precipitated. 
The solution was filtered and the solid obtained was washed ethanol. The precipitated solid was 
recrystallized from appropriate solvent to afford the desired compound. 
(2E,2'Z)-2,2'-[6,6'-(E)-But-2-ene-1,4-diylbis(oxy)bis(3-bromo-6,1-phenylene)]bis(methan -1-
yl-1-ylidene)bis(hydrazinecarbothioamide) (3a). The solid obtained was washed with H2O and 
recrystallized, (yield: 68%); mp 258 oC (from DMF-EtOH-H2O, 1:2:1) (Found: C, 40.05; H, 
3.32; N, 13,97. C20H20Br2N6O2S2 requires C, 40.01; H, 3.36; N, 14.00%); IR (KBr) (ν, cm-1), 
3150-3263 (NH2), 3149 ( -NH-), 3016 ( Ar-CH), 1592 (C=N); 1H-NMR (DMSO-d6) δ (ppm) 
4.67 (s, 4H, O-CH2), 6.19 (s, 2H, HC=CH-), Ar-H [7.03-7.04 (d, 2H), 7.48-7.53 (d, 2H), 8.24 (s, 
2H)], 8.46 (s, 2H, CH=N), 8.24 (s, 2H, NH2), 8.37 (s, 2H, NH2), 11.56 (s, 2H, -NH); 13C-NMR 
(DMSO-d6) δ (ppm) 67.72 (O-CH2), Ar-C [112.98 (C), 114.89 (CH), 124.52 (C), 126.99 (CH), 
128.02 (CH), 155.55 (C)], 133.14 (CH=CH), 136.13 (CH=N), 177.76 (C=S); MS(ESI-m/z): 
(M+1)+: 599.01; Anal. for C20H20Br2N6O2S2 (Mw 597.95). 
(2Z,2'Z)-2,2'-[4,4'-(E)-But-2-ene-1,4-diylbis(oxy)bis(3-methoxy-4,1-phenylene)]bis-(methan-
1-yl-1-ylidene)bis(hydrazinecarbothioamide) (3b). The solid obtained was washed with H2O 
and recrystallized, (yield: 61%); mp 205-206 oC (from DMF-EtOH-H2O, 1:2:1) (Found: C, 
52.51, H: 5.26, N: 16.81. C22H26N6O4S2 requires C, 52.57; H, 5.21; N, 16.72%); IR (KBr) (ν, cm-
1), 3155-3269 (NH2), 3155 (-NH-), 3037 (Ar-CH), 1599 (C=N). 1H-NMR (DMSO-d6) δ (ppm) 
3.83 (s, 6H, OCH3), 4.63 (s, 4H, O-CH2), 6.08 (s, 2H, -HC=CH-), Ar-H [6.96-7.00 (d, 2H), 7.11-
7.15 (d, 2H), 7.54 (s, 2H)], 7.97 (s, 2H, CH=N), 8.05 (s, 2H, NH2), 8.17 (s, 2H, NH2), 11.34 (s, 
2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 55.55 (OCH3), 67.59 (O-CH2), Ar-C [108.49 (CH), 
112.36 (CH), 121.91 (CH), 126.99 (C), 149.14 (C), 149.19 (C)], 128.33 (CH=CH), 142.30 
(CH=N), 177.34 (C=S); MS(ESI-m/z): (M+1)+: 503.32; Anal. for C22H26N6O4S2 (Mw 502.15). 
(2E,2'Z)-2,2'-[2,2'-(E)-But-2-ene-1,4-diylbis(oxy)bis(naphthalene-2,1-diyl)]bis(methan-1-yl-
1-ylidene)bis(hydrazinecarbothioamide) (3c). The solid obtained was washed with H2O and 
recrystallized, (yield: 42%); mp 217 oC (from DMF-EtOH, 1:1) (Found: C, 61.91; H, 4.31; N, 
15.54. C28H26N6O4S2 requires C, 61.97; H, 4.83; N, 15.49%); IR (KBr) (ν, cm-1), 3242-3152 
(NH2), 3150 (-NH-), 3054 (Ar-CH), 1590 (C=N); 1H-NMR (DMSO-d6) δ (ppm) 4.87 (s, 4H, O-
CH2), 6.26 (s, 2H, -HC=CH-), Ar-H [7.44-7.58 (m, 8H), 7.91-7.98 (bs, 4H)], 8.97 (s, 2H, 
CH=N), 8.29 (s, 4H, NH2), 11.68 (s, 2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 65.45 (O-CH2), 
Ar-C [113.63 (C), 114.48 (CH), 123.74 (CH), 125.49 (CH), 127.91 (CH), 128.32 (CH), 128.83 
(C), 131.01 (CH), 132.25 (C), 156.95 (C)], 128.57 (CH=CH), 145.79(CH=N), 177.74 (C=S); 
MS(ESI-m/z): (M+1)+: 543.27; Anal. for C28H26N6O4S2 (Mw 542.16). 
(2Z,2'Z)-2,2'-[1,1'-(4,4'-(E)-But-2-ene-1,4-diylbis(oxy)bis(4,1-phenylene)]bis(ethan-1-yl-1-
ylidene))bis(hydrazinecarbothioamide) (3d). The solid obtained was washed with H2O and 
recrystallized, (yield: 58%); mp 229-230 oC (from DMSO-EtOH, 1:1) (Found: C, 56.09; H, 5.61; 
N, 17.89. C22H26N6O2S2 requires C, 56.15; H, 5.57; N, 17.86%); IR (KBr) (ν, cm-1), 3139-3224 
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(NH2), 3140 (-NH-), 3043 (Ar-CH), 1598 (C=N). 1H-NMR (DMSO-d6) δ (ppm) 2.24 (s, 6H, 
CH3), 4.63 (s, 4H, O-CH2), 6.05 (s, 2H, -HC=CH-), Ar-H [6.90-6.94 (d, 4H), 7.85-7.89 (d, 4H)], 
7.89 (s, 2H, NH2), 8.22 (s, 2H, NH2), 10.11 (s, 2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 13.75 
(CH3), 67.06 (O-CH2), Ar-C [114.11 (CH), 128.04 (C), 130.06 (CH), 158.96 (C)], 128.20 
(CH=CH), 147.63 (CH=N), 178.43 (C=S); MS(ESI-m/z): (M+1)+: 471.29; Anal. for 
C22H26N6O2S2 (Mw 470.16). 
(2E,2'Z)-2,2'-[6,6'-(E)-But-2-ene-1,4-diylbis(oxy)bis(3-bromo-6,1-phenylene)]bis-(methan-
1-yl-1-ylidene)bis(N-methylhydrazinecarbothioamide) (3e). The solid obtained was washed 
with H2O and recrystallized, (yield: 73%); mp 254 oC (from DMSO-EtOH, 1:1) (Found: C, 
41.99; H, 3.88; N, 13.42. C22H24Br2N6O2S2 requires C, 42.05; H, 3.85; N, 13.37%); IR (KBr) (ν, 
cm-1), 3133-3310 (-NH-), 3071 (Ar-CH), 1585 (C=N); 1H-NMR (DMSO-d6) δ (ppm) 3.01-3.03 
(d, 6H, -NCH3), 4.69 (s, 4H, O-CH2), 6.19 (s, 2H, -HC=CH-), Ar-H [7.04-7.08 (dd, 2H), 7.48-
7.54 (dd, 2H), 8.31-8.32 (d, 2H)], 8.45 (s, 2H, CH=N), 8.64-8.66 (d, 2H, -NH-CH3), 11.63 (s, 
2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 30.73 (-NCH3), 67.75 (O-CH2), Ar-C [112.94 (C), 
114.98 (CH), 124.62 (C), 127.03 (CH), 133.09 (CH), 155.54 (C)], 127.76 (HC=CH), 135.67 
(CH=N), 177.47 (C=S); MS(ESI-m/z): (M+1)+: 626.94; Anal. for C22H24Br2N6O2S2 (Mw 
625.98). 
(2Z,2'Z)-2,2'-[4,4'-(E)-But-2-ene-1,4-diylbis(oxy)bis(3-methoxy-4,1-phenylene)]bis-(methan-
1-yl-1-ylidene)bis(N-methylhydrazinecarbothioamide) (3f). The solid obtained was washed 
with H2O and recrystallized, (yield: 65%); mp 202 oC (from DMF-EtOH, 1:1) (Found: C, 54.28; 
H, 5.62; N, 15.96. C24H30N6O4S2 requires C, 54.32; H, 5.70; N, 15.84%); IR (KBr) (ν, cm-1), 
3175-3293 (-NH-), 3065 (Ar-CH), 1602 (C=N); 1H-NMR (DMSO-d6) δ (ppm) 3.02-3.04 (d, 6H, 
-NCH3), 3.84 (s, 6H, OCH3), 4.64 (s, 4H, O-CH2), 6.09 (s, 2H, -HC=CH-), Ar-H [6.98-7.02 (d, 
2H), 7.18-7.21 (d, 2H), 7.47 (s, 2H)], 7.97 (s, 2H, CH=N), 8.42-8.44 (d, 2H, -NH-CH3), 11.40 (s, 
2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 30.73 (-NCH3), 55.61 (OCH3), 67.64 (O-CH2), Ar-C 
[109.01 (CH), 112.55 (CH), 121.54 (CH), 127.06 (C), 149.10 (C), 149.17 (C)], 128.37 
(HC=CH), 141.89 (CH=N), 177.30 (C=S); MS(ESI-m/z): (M+1)+: 531.35; Anal. for 
C24H30N6O4S2 (Mw 530.18). 
(2E,2'Z)-2,2'-[2,2'-(E)-But-2-ene-1,4-diylbis(oxy)bis(naphthalene-2,1-diyl)]bis(methan-1-yl-
1-ylidene)bis(N-methylhydrazinecarbothioamide) (3g). The solid obtained was washed with 
H2O and recrystallized, (yield: 72%); mp 228 oC (from DMF-EtOH, 1:1) (Found: C, 63.02; H, 
5.37; N, 14.68. C30H30N6O2S2 requires C, 63.13; H, 5.30; N, 14.73%); IR (KBr) (ν, cm-1), 3377-
3162 (-NH-), 3039 (Ar-CH), 1622 (C=N); 1H-NMR (DMSO-d6) δ (ppm) 3.05-3.07 (d, 6H, -
NCH3), 4.87 (s, 4H, O-CH2), 6.27 (s, 2H, HC=CH-), Ar-H [7.39-7.64 (m, 6H), 7.88-8.02 (m, 
4H), 8.89-8.94 (d, 2H)], 8.87 (s, 2H, CH=N), 8.14-8.16 (d, 2H, -NH-CH3), 11.67 (s, 2H, -NH); 
13C-NMR (DMSO-d6) δ (ppm) 31.06 (-NCH3), 68.68 (O-CH2), Ar-C [114.38 (C), 114.78 (CH), 
123.98 (CH), 125.47 (CH), 127.98 (CH), 128.06 (CH), 128.66 (C), 130.60 (CH), 132.02 (C), 
156.54 (C)], 128.24 (HC=CH), 140.69 (CH=N), 177.45 (C=S); MS(ESI-m/z): (M+1)+:571.25; 
Anal. for C30H30N6O2S2 (Mw 570.19). 
(2Z,2'Z)-2,2'-{1,1'-[4,4'-(E)-But-2-ene-1,4-diylbis(oxy)bis(4,1-phenylene)]bis(ethan-1-yl-1-
ylidene)}bis(N-methylhydrazinecarbothioamide) (3h). The solid obtained was washed with 
H2O and recrystallized, (yield: 60%); mp 246-247 oC (from DMF-EtOH, 1:2) (Found: C, 57.75; 
H, 6.08; N, 16.79. C24H30N6O2S2 requires C, 57.81; H, 6.06; N, 16.85%); IR (KBr) (ν, cm-1), 
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3313-3175 (-NH-), 3048 (Ar-CH), 1602 (C=N); 1H-NMR (DMSO-d6) δ (ppm) 2.27 (s, 6H, 
CH3), 3.04-3.06 (d, 6H, -NCH3), 4.66 (s, 4H, O-CH2), 6.09 (s, 2H, -HC=CH-), Ar-H [6.95-6.99 
(d, 4H), 7.88-7.93 (d, 4H)], 8.43-8.45 (d, 2H, -NH-CH3), 10.18 (s, 2H, -NH); 13C-NMR (DMSO-
d6) δ (ppm) 13.74 (CH3), 30.93 (-NCH3), 67.07 (O-CH2), Ar-C: [114.09 (CH), 127.98 (C), 
130.11 (CH), 158.91 (C)], 128.20 (HC=CH), 147.31 (CH=N), 178.13 (C=S); MS(ESI-m/z): 
(M+1)+: 499.28; Anal. for C24H30N6O2S2 (Mw 498.67). 
 
General method for the synthesis tetra 4-methyl-5-ethoxy carbonyl-1,3-thiazole 4 
To a solution of 3a-h compounds (0.5 mmol) in absolute ethanol (60 ml) were added ethyl-2-
chloro-acetoacetate (2.0 mmol). After the mixture was refluxed and stirred for 80 h, the solution 
was filtered and the solid obtained was washed with ethanol and deionized water. The 
precipitated solid was recrystallized from appropriate solvent to afford the desired compound. 
(Z)-Ethyl 2-((Z)-(5-bromo-2-((E)-4-(4-bromo-2-((E)-((Z)-(5-(ethoxycarbonyl)-4-methyl-thiazol- 
2(3H)-ylidene)hydrazono)methyl)phenoxy)but-2-enyloxy)benzylidene)hydrazono)-4-methyl- 2,3-
dihydrothiazole-5-carboxylate (4a). The solid obtained was washed with H2O and 
recrystallized, (yield: 48%); mp 217 oC (from DMF-EtOAc, 1:2) (Found: C, 46.75; H, 3.96; N, 
10.19. C32H32Br2N6O6S2 requires C, 46.84; H, 3.93; N, 10.24%; IR (KBr) (ν, cm-1), 3153 (-NH-), 
3049 (Ar-CH), 1682 (C=O), 1592 (C=N), 1089 (OCH2CH3). 1H-NMR (DMSO-d6) δ (ppm) 1.23-
1.30 (t, 6H, OCH2CH3), 2.47 (s, 6H, thiazole-CH3), 4.16-4.26 (q, 4H, OCH2CH3), 4.73 (s, 4H, O-
CH2), 6.14 (s, 2H, -HC=CH-), Ar-H [7.08-7.12 (d, 4H), 7.51-7.57 (dd, 2H), 7.83-7.84 (d, 2H)], 
8.39 (s, 2H, CH=N), 12.41 (s, 2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 12.52 (OCH2CH3), 
14.22 (thiazole-CH3), 60.23 (OCH2CH3), 65.94 (O-CH2), Ar-C [113.92 (C), 114.17 (CH), 124.52 
(C), 126.61 (CH), 128.06 (CH), 155.67 (C)], thiazole-C [109.25 (C), 148.14 (C), 161.89 (C)], 
132.29 (HC=CH), 147.75 (CH=N), 168.50 (C=O); MS(ESI-m/z): (M+ Na)+: 843.50; Anal. for 
C32H32Br2N6O6S2 (Mw 820.57). 
(2Z,2'Z)-Diethyl 2,2'-{(2Z,2'Z)-[4,4'-(E)-but-2-ene-1,4-diylbis(oxy)bis(3-methoxy-4,1-phenylene)] 
bis(methan-1-yl-1-ylidene)bis(hydrazine-2,1-diylidene)}bis(4-methyl-2,3-dihydrothiazole-5-
carboxylate) (4b). The solid obtained was washed with H2O and recrystallized, (yield: 48%); 
mp 192 oC (from DMF-EtOH, 1:1) (Found: C, 56.47; H, 5.28; N, 11.68. C34H38N6O8S2 requires 
C, 56.50; H, 5.30; N, 11.63%); IR (KBr) (ν, cm-1), 3150 (-NH-), 3027 (Ar-CH), 1705 (C=O), 
1599 (C=N), 1087 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 1.23-1.30 (t, 6H, OCH2CH3), 2.47 
(s, 6H, thiazole-CH3), 3.82 (s, 6H, OCH3), 3.83-4.22 (q, 4H, OCH2CH3), 4.65 (s, 4H, O-CH2), 
6.10 (s, 2H, -HC=CH-), Ar-H [7.01-7.05 (d, 2H), 7.17-7.21 (d, 2H), 7.28 (s, 2H)], 8.02 (s, 2H, 
CH=N), 12.36 (s, 2H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 14.20 (OCH2CH3), 16.99 (thiazole-
CH3), 55.31 (OCH3), 59.92 (OCH2CH3), 67.62 (O-CH2), Ar-C [108.76 (CH), 112.87 (CH), 
120.52 (CH), 126.76 (C), 149.08 (C), 149.13 (C)], thiazole-C [108.57 (C), 158.26 (C), 162.73 
(C)], 128.39 (HC=CH), 144.58 (CH=N), 168.84 (C=O); MS(ESI-m/z): (M+1)+: 723.37; Anal. for 
C34H38N6O8S2 (Mw 722.83). 
((Z)-Ethyl 2-((E)-((2-((E)-4-(1-((Z)-((Z)-(5-(ethoxycarbonyl)-4-methylthiazol-2(3H)-ylid-ene) 
hydrazono)methyl)naphthalen-2-yloxy)but-2-enyloxy)naphthalen-1-yl)methylene)-hydrazono)- 
4-methyl-2,3-dihydrothiazole-5-carboxylate (4c). The solid obtained was washed with H2O 
and recrystallized, (yield: 56%); mp 203 oC (from DMF-EtOH, 2:3) (Found C, 62.92; H, 5.06; N, 
11.09. C40H38N6O6S2 requires C, 62.97; H, 5.02; N, 11.02%); IR (KBr) (ν, cm-1), 3170 (-NH-), 
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3049 (Ar-CH), 1719 (C=O), 1594 (C=N), 1091 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 1.23-
1.29 (t, 6H, OCH2CH3), 2.47 (s, 6H, thiazole-CH3), 4.13-4.24 (q, 4H, OCH2CH3), 4.82 (s, 4H, O-
CH2), 6.13 (s, 2H, -HC=CH-), Ar-H [7.24-7.46 (m, 6H), 7.54-7.72 (m, 4H), 8.97-9.43 (d, 2H)], 
8.89 (s, 2H, CH=N), 12.39 (s, 4H, -NH); 13C-NMR (DMSO-d6) δ (ppm) 13.87 (OCH2CH3), 
17.04 (thiazole-CH3), 60.01 (OCH2CH3), 67.56 (O-CH2), Ar-C [114.40 (C), 118.15 (CH), 124.08 
(CH), 125.52 (CH), 127.12 (CH), 128.51 (CH), 128.94 (C), 130.67 (CH), 132.44 (C), 156.89 
(C)], thiazole-C: [102.26 (C), 158.85 (C), 161.89 (C)], 130.18 (HC=CH), 146.89 (CH=N), 
167.84 (C=O); MS(ESI-m/z): (M+1)+: 763.29; Anal. for C40H38N6O6S2 (Mw 762.23). 
(2Z,2'Z)-Diethyl 2,2'-((2Z,2'Z)-(1,1'-(4,4'-(E)-but-2-ene-1,4-diylbis(oxy)bis(4,1-phenylene)) 
bis(ethan-1-yl-1-ylidene))bis(hydrazine-2,1-diylidene))bis(4-methyl-2,3-dihydrothiazole-5-
carboxylate) (4d). The solid obtained was washed with H2O and recrystallized, (yield: 53%; mp 
144-145 oC (from DMF-Et2O, 1:2) (Found: C, 59.07; H, 5.56; N, 12.21. C34H38N6O6S2 requires 
C, 59.11; H, 5.54; N, 12.17%); IR (KBr) (ν, cm-1), 3197 (-NH-), 3052 (Ar-CH), 1712 (C=O), 
1611 (C=N), 1103 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 1.23-1.30 (t, 6H, OCH2CH3), 2.28 
(s, 6H, CH3), 2.48 (s, 6H, thiazole-CH3), 4.15-4.25 (q, 4H, OCH2CH3), 4.66 (s, 4H, O-CH2), 6.09 
(s, 2H, -HC=CH-), Ar-H [6.99-7.03 (d, 4H), 7.14-7.76 (d, 4H)], 11.69 (s, 2H, -NH); 13C-NMR 
(DMSO-d6) δ (ppm) 14.06 (CH3), 14.22 (OCH2CH3), 16.55 (thiazole-CH3), 59.92 (OCH2CH3), 
67.07 (O-CH2), Ar-C [114.12 (CH), 127.25 (C), 130.06 (CH), 156.36 (C)], thiazole-C [109.64 
(C), 158.89 (C), 161.85 (C)], 128.29 (HC=CH), 147.89 (CH=N), 165.22 (C=O); MS(ESI-m/z): 
(M+1)+: 691.35; Anal. for C34H38N6O6S2 (Mw 690.23). 
(Z)-Ethyl 2-((Z)-(5-bromo-2-((E)-4-(4-bromo-2-((E)-((Z)-(5-(ethoxycarbonyl)-3,4-dimethylthiazol-
2(3H)- ylidene)hydrazono)methyl)phenoxy)but-2-enyloxy)benzylidene)hydrazono)-3,4-dimethyl- 
2,3-dihydrothiazole-5-carboxylate (4e). The solid obtained was washed with H2O and 
recrystallized, (yield: 56%); mp 257 oC (from DMSO) (Found: C, 48.07; H, 4.31; N, 9.87. 
C34H36Br2N6O6S2 requires C, 48.12; H, 4.28; N, 9.90%); IR (KBr) (ν, cm-1), 3042 (Ar-CH), 1698 
(C=O), 1598 (C=N), 1087 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 1.32-1.39 (t, 6H, 
OCH2CH3), 2.57 (s, 6H, thiazole-CH3), 3.47 (s, 6H, N-CH3), 4.24-4.34 (q, 4H, OCH2CH3), 4.59 
(s, 4H, O-CH2), 6.06 (s, 2H, -HC=CH-), Ar-H [6.72-6.77 (d, 2H), 7.26-7.40 (dd, 2H), 8.17-8.18 
(d, 2H)], 8.66 (s, 2H, CH=N); 13C-NMR (DMSO-d6) δ (ppm) 12.83 (OCH2CH3), 14.43 (thiazole-
CH3), 31.60 (N-CH3), 60.85 (OCH2CH3), 68.36 (O-CH2), Ar-C [113.88 (C), 114.23 (CH), 
126.19 (C), 128.08 (CH), 129.28 (CH), 155.80 (C)], thiazole-C [103.86 (C), 146.64 (C), 162.19 
(C)], 133.12 (HC=CH), 147.32 (CH=N), 168.31 (C=O); MS(ESI-m/z): (M+1)+: 849.29; Anal. for 
C34H36Br2N6O6S2 (Mw 848.62). 
(2Z,2'Z)-Diethyl 2,2'-((2Z,2'Z)-(4,4'-(E)-but-2-ene-1,4-diylbis(oxy)bis(3-methoxy-4,1-phenylene))bis 
(methan-1-yl-1-ylidene)bis(hydrazine-2,1-diylidene))bis(3,4-dimethyl-2,3-dihydrothiazole- 
5-carboxylate) (4f). The solid obtained was washed with H2O and recrystallized, (yield: 54%); 
mp 232-233 oC (from DMF-EtOH, 1:1) (Found: C, 57.57; H, 5.69; N, 11.25. C36H42N6O8S2 
requires C, 57.58; H, 5.64; N, 11.19%); IR (KBr) (ν, cm-1), 3082 (Ar-CH), 1690 (C=O), 1601 
(C=N), 1088 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 1.22-1.29 (t, 6H, OCH2CH3), 2.55 (s, 
6H, thiazole-CH3), 3.42 (s, 6H, N-CH3), 3.82 (s, 6H, OCH3), 4.19-4.23 (q, 4H, OCH2CH3), 4.65 
(s, 4H, O-CH2), 6.09 (s, 2H, -HC=CH-), Ar-H [7.01-7.05 (d, 2H), 7.22-7.26 (d, 2H), 7.35 (s, 
2H)], 8.27 (s, 2H, CH=N); 13C-NMR (DMSO-d6) δ (ppm) 12.31 (OCH2CH3), 14.15 (thiazole-
CH3), 31.26 (N-CH3), 55.39 (OCH3), 60.17 (OCH2CH3), 65.63 (O-CH2), Ar-C [109.39 (CH), 
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114.06 (CH), 120.93 (CH), 128.31 (C), 149.28 (C), 153.24 (C)], thiazole-C [101.13 (C), 160.87 
(C), 165.69 (C)], 131.23 (HC=CH), 148.02 (CH=N), 169.38 (C=O); MS(ESI-m/z): (M+Na)+: 
773.54; Anal. for C36H42N6O8S2 (Mw 750.88). 
(Z)-Ethyl 2-((E)-((2-((E)-4-(1-((Z)-((Z)-(5-(ethoxycarbonyl)-3,4-dimethylthiazol-2(3H)-
ylidene)hydrazono)methyl)naphthalen-2-yloxy)but-2-enyloxy)naphthalen-1-yl)methyl-ene) 
hydrazono)-3,4-dimethyl-2,3-dihydrothiazole-5-carboxylate (4g). The solid obtained was 
washed with H2O and recrystallized, (yield: 49%); mp 179 oC (from DMF-Et2O, 1:2) (Found: C, 
63.71; H, 5.39; N, 10.70. C42H42N6O6S2 requires C, 63.78; H, 5.35; N, 10.63%); IR (KBr) (ν, cm-
1), 3038 (Ar-CH), 1702 (C=O), 1590 (C=N), 1095 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 
1.23-1.30 (t, 6H, OCH2CH3), 2.54 (s, 6H, thiazole-CH3), 3.42 (s, 6H, N-CH3), 4.17-4.24 (q, 4H, 
OCH2CH3), 4.89 (s, 4H, O-CH2), 6.22 (s, 2H, -HC=CH-), Ar-H [7.43-7.60 (m, 6H), 7.88-7.99 
(m, 4H), 9.27-9.91 (d, 2H)], 9.06 (s, 2H, CH=N); 13C-NMR (DMSO-d6) δ (ppm) 12.31 
(OCH2CH3), 14.00 (thiazole-CH3), 31.08 (N-CH3), 60.22 (OCH2CH3), 68.10 (O-CH2), Ar-C 
[114.38 (C), 118.02 (CH), 123.43 (CH), 125.22 (CH), 126.02 (CH), 127.77 (CH), 127.88 (C), 
127.98 (CH), 130.34 (C), 153.50 (C)], thiazole-C [101.04 (C), 147.97 (C), 161.22 (C)], 130.50 
(HC=CH), 147.60 (CH=N), 166.26 (C=O); MS(ESI-m/z): (M+1)+: 792.37; Anal. for 
C42H42N6O6S2 (Mw 790.95). 
(2Z,2'Z)-Diethyl 2,2'-[(2Z,2'Z)-{1,1'-[4,4'-(E)-but-2-ene-1,4-diylbis(oxy)bis(4,1-phenylene )] 
bis(ethan-1-yl-1-ylidene)}bis(hydrazine-2,1-diylidene)]bis(3,4-dimethyl-2,3-dihydro-thiazole- 5-
carboxylate) (4h). The solid obtained was washed with H2O and recrystallized, (yield: 61%); 
mp 240 oC (from DMF-Et2O, 1:2) (Found: C, 60.09; H, 5.93; N, 11.66. C36H42N6O6S2 requires 
C, 60.15; H, 5.89; N, 11.69%); IR (KBr) (ν, cm-1), 3054 (Ar-CH), 1672 (C=O), 1590 (C=N), 
1095 (OCH2CH3); 1H-NMR (DMSO-d6) δ (ppm) 1.19-1.26 (t, 6H, OCH2CH3), 2.34 (s, 6H, 
CH3), 2.53 (s, 6H, thiazole-CH3), 3.43 (s, 6H, N-CH3), 4.16-4.19 (q, 4H, OCH2CH3), 4.63 (s, 4H, 
O-CH2), 6.07 (s, 2H, -HC=CH-), Ar-H [6.95-6.99 (d, 4H), 7.74-7.79 (d, 4H)]; 13C-NMR 
(DMSO-d6) δ (ppm) 12.49 (CH3), 14.05 (OCH2CH3), 14.17 (thiazole-CH3), 31.42 (N-CH3), 
60.21 (OCH2CH3), 67.08 (O-CH2), Ar-C [114.35 (CH), 127.36 (C), 130.74 (CH), 156.21 (C)], 
thiazole-C [113.48 (C), 158.95 (C), 161.47 (C)], 128.40 (HC=CH), 148.23 (CH=N), 165.13 
(C=O); MS(ESI-m/z): (M)+: 719.00; Anal. for C36H42N6O6S2 (Mw 718.89). 
 
General method for the synthesis bis(1,3,4-thiadiazol-2-amine) 6 
(E)-1,4-Bis-thiocyanato-but-2-ene 5 (0.05 mol) and thiosemicarbazite or 4-methyl 
thiosemicarbazite (0.10 mol) in trifluoroacetic acid (5 ml) were refluxed at 60-70 °C for 4 h in oil 
bath with stirring. The reaction mixture was poured into ice-cold water (200 ml) and neutralized 
with ammonia. The solid obtained was washed with H2O and crystallized from an appropriate 
solvent to afford the desired compound. 
5-[(E)-4-(5-amino-1,3,4-thiadiazol-2-ylthio)but-2-enylthio]-1,3,4-thiadiazol-2-amine (6k). 
The solid obtained was washed with H2O and recrystallized, (yield: 84%); mp 218 oC (from 
DMF-EtOH, 1:2) (Found: C, 40.13; H, 3.21; N, 26.38. C8H10N6S4 requires C, 40.17; H, 3.16; N, 
26.39%); IR (KBr) (ν, cm-1), 3153-3287 (Ar-NH2), 3098 (Ar-CH), 1640 (C=N); 1H-NMR 
(DMSO-d6) δ (ppm) 3.69 (s, 4H, S-CH2), 5.76 (s, 2H, -HC=CH-), 7.31 (s, 4H, NH2); 13C-NMR 
(DMSO-d6) δ (ppm) 35.77 (S-CH2), tiadiazole-C [ 149.24 (C), 169.70 (C)], 128.96 (-HC=CH-); 
MS(ESI-m/z): (M+1)+1: 319.22; Anal. for C8H10N6S4 (Mw 318.47). 
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5-{(E)-4-[5-(Methylamino)-1,3,4-thiadiazol-2-ylthio]but-2-enylthio}-N-methyl-1,3,4-
thiadiazol- 2-amine (6l). The solid obtained was washed with H2O and recrystallized, (yield: 
84%); mp 229 oC (from DMF-EtOH, 1:2) (Found: C, 34.59; H, 4.11; N, 24.19. C10H14N6S4 
requires C, 34.66; H, 4.07; N, 24.25%); IR (KBr) (ν, cm-1), 3209 (-NH-), 3087 (Ar-CH), 1602 
(C=N); 1H-NMR (DMSO-d6) δ (ppm) 2.83-2.85 (d, 6H, N-CH3), 3.85 (s, 4H, S-CH2), 5.89 (s, 
2H, -HC=CH-), 7.77-7.79 (d, 2H, NH); 13C-NMR (DMSO-d6) δ (ppm) 31.11 (-NCH3), 35.38 (S-
CH2), thiadiazole-C [ 147.89 (C), 170.95 (C)], 129.37 (-HC=CH-); MS(ESI-m/z): (M+1)+1: 
347.63; Anal. for C10H14N6S4 (Mw 346.52). 
 
Assay of antimicrobial activity 
All test microorganisms were obtained from the Hifzissihha Institute of Refik Saydam (Ankara, 
Turkey) and were as follows: Escherichia coli ATCC 35218, Pseudomonas auroginosa ATCC 
10145, Klebsiella pneumoniae ATCC 13883, Enterococcus faecalis ATCC 29212, 
Staphylococcus aureus ATCC 25923, Bacillus cereus 709 ROMA, and Candida albicans ATCC 
60193. All the newly synthesized compounds were dissolved in dimethylformamide (DMF) and 
chloroform (CHCl3) to prepare chemicals stock solution of 4.0-14.0 mg/ml. 
Simple susceptibility screening test using agar-well diffusion method30 as adapted earlier31 was 
used. Each microorganism was suspended in Mueller Hinton (MH) (Difco, Detroit, MI) broth 
and diluted approximately 106 colony forming unit (cfu) per ml. They were “flood-inoculated” 
onto the surface of MH agar and Sabouraud Dextrose Agar (SDA) (Difco, Detriot, MI) and then 
dried. For C. albicans SDA were used. Five-millimeter diameter wells were cut from the agar 
using a sterile cork-borer, and 50 µl of the extract substances were delivered into the wells. The 
plates were incubated for 24-48 h at 35°C. Antimicrobial activity was evaluated by measuring 
the zone of inhibition against the test organism. Ceftazidime (10 µg) and Triflucan (5 µg) were 
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